It is also known that EGFR mutations or amplifications play a role in lung adenocarcinomas [24,25], uveal melanomas [26], and possibly in high-grade gliomas [27], although the role EGFR plays with respect to clinical behavior of the tumor has been controversial [28]. This evidence concerns the gene EGFR and uveal melanoma.